Galapagos NV (GLPG)
29.42
-0.34
(-1.14%)
USD |
NASDAQ |
Apr 02, 16:00
29.50
+0.08
(+0.27%)
After-Hours: 20:00
Galapagos Market Cap : 1.922B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 172.67B |
| UCB SA | 57.37B |
| Celyad Oncology SA | 15.67M |
| Fagron NV | 1.978B |
| AgomAb Therapeutics NV | 472.79M |
Market Cap Related Metrics
| PE Ratio | 4.935 |
| PS Ratio | 1.509 |
| PEG Ratio | 0.0125 |
| Price to Book Value | 0.5101 |
| Price | 29.42 |
| Earnings Yield | 20.26% |
| PEGY Ratio | 0.0125 |
| Operating PE Ratio | 3.420 |
| Normalized PE Ratio | 3.346 |